AU Stock MarketDetailed Quotes

Invex Therapeutics Ltd (IXC)

Watchlist
  • 0.130
  • 0.0000.00%
20min DelayMarket Closed Apr 30 10:17 AET
9.77MMarket Cap-21.67P/E (Static)

Invex Therapeutics Ltd (IXC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities
-81.10%229.17K
164.06%1.21M
151.90%459.09K
182.25K
Income from government grants
-81.10%229.17K
--1.21M
----
----
----
----
Other cash income from operating activities
----
----
151.90%459.09K
--182.25K
----
----
Cash paid
73.14%-1.11M
48.95%-4.15M
-123.29%-8.13M
-98.08%-3.64M
-3.84%-1.84M
-1.77M
Payments to suppliers for goods and services
73.14%-1.11M
48.95%-4.15M
-123.29%-8.13M
-98.08%-3.64M
-3.84%-1.84M
---1.77M
Direct interest received
-52.76%232.35K
-38.30%491.82K
897.84%797.08K
-49.69%79.88K
-4.17%158.79K
--165.7K
Operating cash flow
73.30%-652.57K
64.42%-2.44M
-103.43%-6.87M
-101.20%-3.38M
-4.67%-1.68M
---1.6M
Investing cash flow
Cash flow from continuing investing activities
0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
-14M
-48.56%8.09M
15.73M
Net common stock issuance
----
---14M
----
----
-43.91%8.09M
--14.43M
Net other financing activities
----
----
----
----
----
--1.3M
Cash from discontinued financing activities
Financing cash flow
--0
---14M
----
----
-48.56%8.09M
--15.73M
Net cash flow
Beginning cash position
-73.19%6.03M
-23.41%22.47M
-10.32%29.34M
24.39%32.72M
116.10%26.3M
--12.17M
Current changes in cash
96.03%-652.57K
-139.41%-16.45M
-103.43%-6.87M
-152.63%-3.38M
-54.60%6.42M
--14.13M
Effect of exchange rate changes
--2.56K
----
----
----
----
----
End cash Position
-10.79%5.38M
-73.19%6.03M
-23.41%22.47M
-10.32%29.34M
24.39%32.72M
--26.3M
Free cash from
73.30%-652.57K
64.42%-2.44M
-103.43%-6.87M
-101.20%-3.38M
-4.67%-1.68M
---1.6M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities -81.10%229.17K164.06%1.21M151.90%459.09K182.25K
Income from government grants -81.10%229.17K--1.21M----------------
Other cash income from operating activities --------151.90%459.09K--182.25K--------
Cash paid 73.14%-1.11M48.95%-4.15M-123.29%-8.13M-98.08%-3.64M-3.84%-1.84M-1.77M
Payments to suppliers for goods and services 73.14%-1.11M48.95%-4.15M-123.29%-8.13M-98.08%-3.64M-3.84%-1.84M---1.77M
Direct interest received -52.76%232.35K-38.30%491.82K897.84%797.08K-49.69%79.88K-4.17%158.79K--165.7K
Operating cash flow 73.30%-652.57K64.42%-2.44M-103.43%-6.87M-101.20%-3.38M-4.67%-1.68M---1.6M
Investing cash flow
Cash flow from continuing investing activities 0
Cash from discontinued investing activities
Investing cash flow --0--------------------
Financing cash flow
Cash flow from continuing financing activities 0-14M-48.56%8.09M15.73M
Net common stock issuance -------14M---------43.91%8.09M--14.43M
Net other financing activities ----------------------1.3M
Cash from discontinued financing activities
Financing cash flow --0---14M---------48.56%8.09M--15.73M
Net cash flow
Beginning cash position -73.19%6.03M-23.41%22.47M-10.32%29.34M24.39%32.72M116.10%26.3M--12.17M
Current changes in cash 96.03%-652.57K-139.41%-16.45M-103.43%-6.87M-152.63%-3.38M-54.60%6.42M--14.13M
Effect of exchange rate changes --2.56K--------------------
End cash Position -10.79%5.38M-73.19%6.03M-23.41%22.47M-10.32%29.34M24.39%32.72M--26.3M
Free cash from 73.30%-652.57K64.42%-2.44M-103.43%-6.87M-101.20%-3.38M-4.67%-1.68M---1.6M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus placed on 'ending the war' Show More